These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10065663)

  • 21. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
    Piitulainen E; Tanash HA
    COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
    Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
    Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
    Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
    Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
    Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials.
    Hutchison DC; Cooper D;
    Respir Med; 2002 Nov; 96(11):872-80. PubMed ID: 12418584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
    Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences.
    Xu X; Weiss ST; Rijcken B; Schouten JP
    Eur Respir J; 1994 Jun; 7(6):1056-61. PubMed ID: 7925873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking, lung function, and alpha 1-antitrypsin deficiency.
    Janus ED; Phillips NT; Carrell RW
    Lancet; 1985 Jan; 1(8421):152-4. PubMed ID: 2857224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.
    Seersholm N; Kok-Jensen A
    Thorax; 1998 Apr; 53(4):265-8. PubMed ID: 9741368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Tornling G; Eriksson S
    Thorax; 1998 Nov; 53(11):939-43. PubMed ID: 10193391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
    Abboud RT; Ford GT; Chapman KR;
    Can Respir J; 2001; 8(2):81-8. PubMed ID: 11320399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.
    Tanash HA; Ekström M; Wagner P; Piitulainen E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1663-9. PubMed ID: 27555756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency.
    Piitulainen E; Sveger T
    Acta Paediatr; 1998 Nov; 87(11):1120-4. PubMed ID: 9846912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in severe alpha-1-antitrypsin deficiency (PiZZ).
    Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
    Respir Res; 2010 Apr; 11(1):44. PubMed ID: 20420704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation.
    Camilli AE; Burrows B; Knudson RJ; Lyle SK; Lebowitz MD
    Am Rev Respir Dis; 1987 Apr; 135(4):794-9. PubMed ID: 3565927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exhaled nitric oxide in patients with PiZZ phenotype-related alpha1-anti-trypsin deficiency.
    Malerba M; Clini E; Cremona G; Radaeli A; Bianchi L; Corda L; Pini L; Ricciardolo F; Grassi V; Ambrosino N
    Respir Med; 2001 Jun; 95(6):520-5. PubMed ID: 11421511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of the evidence relating FEV1 decline to giving up smoking.
    Lee PN; Fry JS
    BMC Med; 2010 Dec; 8():84. PubMed ID: 21156048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
    Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
    Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.